Kumpa, Nashrolla .

HRN: 21-73-48  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2022
CEFTRIAXONE 1G (VIAL)
08/08/2022
08/14/2022
IVT
420mg
Od
Pcap D
Waiting Final Action 
08/08/2022
OXACILLIN 500MG (VIAL)
08/08/2022
08/14/2022
İVT
105mg
Q6
Pcap D
Waiting Final Action 
08/09/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/09/2022
08/15/2022
IVT
210mg
Q6
Pcap D
Waiting Final Action 
08/09/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/09/2022
08/15/2022
IVT
63
Q24
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: